News summary

Headlands Research - Summit Portland Celebrates 50 Years of Advancing Alzheimer

Source: PR Newswire • Published: 06 Oct 2026, 04:00

Summarized by Masters of Longevity from PR Newswire.

A celebratory feature highlighting a clinical research site’s 50-year history and evolving role in Alzheimer’s and CNS research.

Headlands Research - Summit Portland Celebrates 50 Years of Advancing Alzheimer
Key Takeaways
  • Headlands Research - Summit Portland has operated since 1976 and conducted over 500 clinical trials.
  • The site contributed to clinical research supporting every FDA-approved class of Alzheimer's medication since 1993.
  • Headlands Summit runs a dedicated Memory Health Center and studies across CNS, cardiometabolic, and vaccine areas.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.